Modulation of nitric oxide (NO) pathways via the AkteNOS axis, improving blood flow, normalizing coagulation, and protecting vascular endothelium, including prevention and reversal of thrombosis in some animal models
This includes vegetarians, vegans, and those with anemiaoften caused by iron deficiency due to blood loss, poor diet, or absorption issuesas well as individuals experiencing chronic fatigue
The follow-up pivotal trial (METAOD006 / OPTIONS) enrolled a larger cohort and failed to replicate statistically significant weight loss, which led Metabolic Pharmaceuticals to halt the formal drug development program in 2007
Inactive ingredients in both formulations: Vegetable glycerin, water, fructose, natural flavorings, potassium sorbate